Headshot of Eric Kandel.

Eric Kandel

University professor emeritus
Columbia University

Eric R. Kandel is university professor emeritus and professor emeritus of physiology and cellular biophysics, psychiatry, biochemistry, molecular biophysics and neuroscience at Columbia University. He is founding co-director of Columbia University’s Zuckerman Institute, founding director of Columbia’s Kavli Institute for Brain Science, and Sagol Professor Emeritus of Brain Science at the Zuckerman Institute. He was also a senior investigator at the Howard Hughes Medical Institute from 1984 to 2022. In 2000, Kandel was awarded the Nobel Prize in Physiology or Medicine for his studies of learning and memory. He has been awarded 24 honorary degrees. Kandel is the author of “In Search of Memory: The Emergence of a New Science of Mind” (2006), “The Age of Insight: The Quest to Understand the Unconscious in Art, Mind and Brain, from Vienna 1900 to the Present” (2012), “Reductionism in Art and Brain Science: Bridging the Two Cultures” (Columbia, 2016), “The Disordered Mind: What Unusual Brains Tell Us About Ourselves” (2018), and “There Is Life After the Nobel Prize” (Columbia, 2022). He is also a co-author of “Principles of Neural Science” (2021), the standard textbook in the field of neuroscience.

From this contributor

Explore more from The Transmitter

Hand holding a vial of microplastics.

Measuring plastic in the brain: Improving, but incomplete

Meanwhile, researchers are publishing papers without “sufficient quality control,” says analytical chemist Dušan Materić.

By Amber Dance
18 September 2026 | 9 min read
Calendar with deadline.

Incredible shrinking grant deadlines at the BRAIN Initiative

“A month is crazy,” says one former recipient, referring to a new funding opportunity’s timeline.

By Brendan Borrell
17 September 2026 | 4 min read

Sylvia Fogel, reshaping U.S. autism research strategy

In a wide-ranging and provocative interview, the chair of the federal Interagency Autism Coordinating Committee shares her views on vaccines, regression, neuroimmune conditions and more.

By Brady Huggett
17 September 2026 | 2 min read